MedTrace Logo

Metacognitive Therapy Compared to Cognitive-behavioral Therapy

NCT07382323 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-02-04

No results posted yet for this study

Summary

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Conditions

Interventions

BEHAVIORAL

Transdiagnostic metacognitive therapy

Metacognitive therapy focuses on metacognitions.

BEHAVIORAL

Disorder-specific cognitive-behavioral therapy

Cognitive-behavioral therapy focuses on cognitions and/or behaviors.

Sponsors & Collaborators

Principal Investigators

  • Benjamin Bohman · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07382323 on ClinicalTrials.gov